• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清星形胶质细胞和神经元标志物与水通道蛋白4及髓鞘少突胶质细胞糖蛋白自身抗体之间的关系。

The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies.

作者信息

Chatanaka Miyo K, Avery Lisa M, Pasic Maria D, Sithravadivel Shanthan, Rotstein Dalia, Demos Catherine, Cohen Rachel, Gorham Taron, Wang Mingyue, Stengelin Martin, Mathew Anu, Sigal George, Wohlstadter Jacob, Prassas Ioannis, Diamandis Eleftherios P

机构信息

Department of Laboratory and Medicine Pathobiology, University of Toronto, 60 Murray St. Box 32, Floor 6, Rm L6-201, Toronto, ON, M5T 3L9, Canada.

Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.

出版信息

Clin Proteomics. 2024 Apr 5;21(1):28. doi: 10.1186/s12014-024-09466-9.

DOI:10.1186/s12014-024-09466-9
PMID:38580905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10998414/
Abstract

BACKGROUND

Certain demyelinating disorders, such as neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) exhibit serum autoantibodies against aquaporin-4 (αAQP4) and myelin oligodendrocyte glycoprotein (αMOG). The variability of the autoantibody presentation warrants further research into subtyping each case.

METHODS

To elucidate the relationship between astroglial and neuronal protein concentrations in the peripheral circulation with occurrence of these autoantibodies, 86 serum samples were analyzed using immunoassays. The protein concentration of glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL) and tau protein was measured in 3 groups of subcategories of suspected NMOSD: αAQP4 positive (n = 20), αMOG positive (n = 32) and αMOG/αAQP4 seronegative (n = 34). Kruskal-Wallis analysis, univariate predictor analysis, and multivariate logistic regression with ROC curves were performed.

RESULTS

GFAP and NFL concentrations were significantly elevated in the αAQP4 positive group (p = 0.003; p = 0.042, respectively), and tau was elevated in the αMOG/αAQP4 seronegative group (p < 0.001). A logistic regression model to classify serostatus was able to separate αAQP4 seropositivity using GFAP + tau, and αMOG seropositivity using tau. The areas under the ROC curves (AUCs) were 0.77 and 0.72, respectively. Finally, a combined seropositivity versus negative status logistic regression model was generated, with AUC = 0.80.

CONCLUSION

The 3 markers can univariately and multivariately classify with moderate accuracy the samples with seropositivity and seronegativity for αAQP4 and αMOG.

摘要

背景

某些脱髓鞘疾病,如视神经脊髓炎谱系障碍(NMOSD)和髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD),表现出针对水通道蛋白4(αAQP4)和髓鞘少突胶质细胞糖蛋白(αMOG)的血清自身抗体。自身抗体表现的变异性值得对每个病例进行进一步的亚型研究。

方法

为了阐明外周循环中星形胶质细胞和神经元蛋白浓度与这些自身抗体出现之间的关系,使用免疫测定法分析了86份血清样本。在疑似NMOSD的3组亚类中测量了胶质纤维酸性蛋白(GFAP)、神经丝轻链(NFL)和tau蛋白的蛋白浓度:αAQP4阳性(n = 20)、αMOG阳性(n = 32)和αMOG/αAQP4血清阴性(n = 34)。进行了Kruskal-Wallis分析、单变量预测分析以及带有ROC曲线的多变量逻辑回归分析。

结果

αAQP4阳性组中GFAP和NFL浓度显著升高(分别为p = 0.003;p = 0.042),αMOG/αAQP4血清阴性组中tau升高(p < 0.001)。用于分类血清状态的逻辑回归模型能够使用GFAP + tau区分αAQP4血清阳性,使用tau区分αMOG血清阳性。ROC曲线下面积(AUC)分别为0.77和0.72。最后,生成了一个联合血清阳性与阴性状态的逻辑回归模型,AUC = 0.80。

结论

这3种标志物能够以中等准确性对αAQP4和αMOG血清阳性和血清阴性样本进行单变量和多变量分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/052d704f9b18/12014_2024_9466_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/2acff70648b3/12014_2024_9466_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/7200b12ce406/12014_2024_9466_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/0deff0e0eb4e/12014_2024_9466_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/052d704f9b18/12014_2024_9466_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/2acff70648b3/12014_2024_9466_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/7200b12ce406/12014_2024_9466_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/0deff0e0eb4e/12014_2024_9466_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f91/10998414/052d704f9b18/12014_2024_9466_Fig4_HTML.jpg

相似文献

1
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies.血清星形胶质细胞和神经元标志物与水通道蛋白4及髓鞘少突胶质细胞糖蛋白自身抗体之间的关系。
Clin Proteomics. 2024 Apr 5;21(1):28. doi: 10.1186/s12014-024-09466-9.
2
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies.血清星形胶质细胞和神经元标志物与水通道蛋白4及髓鞘少突胶质细胞糖蛋白自身抗体之间的关系。
Res Sq. 2023 Nov 29:rs.3.rs-3659922. doi: 10.21203/rs.3.rs-3659922/v1.
3
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.血清生物标志物谱可区分 AQP4 血清阳性和双血清阴性视神经脊髓炎谱系障碍。
Neurol Neuroimmunol Neuroinflamm. 2024 Jan;11(1):e200188. doi: 10.1212/NXI.0000000000200188. Epub 2023 Dec 22.
4
Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.血清神经丝轻链和 GFAP 与水通道蛋白 4 或髓鞘少突胶质细胞糖蛋白抗体阳性的炎症性疾病的严重程度相关。
Front Immunol. 2021 Mar 16;12:647618. doi: 10.3389/fimmu.2021.647618. eCollection 2021.
5
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.脑脊液 GFAP 水平在双血清阴性视神经脊髓炎谱系疾病中的变化:无星形胶质细胞损伤的证据。
J Neuroinflammation. 2022 Apr 12;19(1):86. doi: 10.1186/s12974-022-02450-w.
6
Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.髓鞘少突胶质细胞糖蛋白抗体相关性疾病的血清生物标志物。
Neurol Neuroimmunol Neuroinflamm. 2020 Mar 17;7(3). doi: 10.1212/NXI.0000000000000708. Print 2020 May.
7
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.血清 GFAP 和 NfL 作为水通道蛋白-4 抗体阳性视神经脊髓炎谱系疾病的疾病严重程度和预后生物标志物。
J Neuroinflammation. 2021 May 1;18(1):105. doi: 10.1186/s12974-021-02138-7.
8
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.髓鞘少突胶质细胞糖蛋白相关疾病和水通道蛋白 4 抗体阳性视神经脊髓炎谱系疾病外周炎症反应增加。
Front Immunol. 2022 Nov 14;13:1037812. doi: 10.3389/fimmu.2022.1037812. eCollection 2022.
9
Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.血清神经丝蛋白与水通道蛋白 4 抗体阳性视神经脊髓炎谱系疾病的视网膜结构损伤相关。
Mult Scler Relat Disord. 2022 Nov;67:104100. doi: 10.1016/j.msard.2022.104100. Epub 2022 Aug 9.
10
Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.胶质纤维酸性蛋白作为视神经脊髓炎谱系障碍的生物标志物:当前综述
Expert Rev Clin Immunol. 2023 Jan;19(1):71-91. doi: 10.1080/1744666X.2023.2148657. Epub 2022 Nov 30.

本文引用的文献

1
Serum neurofilament and glial fibrillary acidic protein in idiopathic and seropositive transverse myelitis.特发性和血清阳性横贯性脊髓炎患者的血清神经丝和胶质纤维酸性蛋白。
Mult Scler Relat Disord. 2023 Nov;79:104957. doi: 10.1016/j.msard.2023.104957. Epub 2023 Sep 1.
2
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.视神经脊髓炎谱系疾病(NMOSD)的诊断和治疗进展——视神经脊髓炎研究组(NEMOS)的修订建议。第二部分:发作期治疗和长期管理。
J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7.
3
Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder.
快速免疫印迹 AQP4 检测在视神经脊髓炎谱系疾病中的应用。
JAMA Neurol. 2023 Oct 1;80(10):1105-1112. doi: 10.1001/jamaneurol.2023.2974.
4
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.血清神经丝轻链水平在发作时预测发作后残疾恶化,并被依鲁替尼减轻:视神经脊髓炎谱系障碍中四个潜在生物标志物的分析。
J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):757-768. doi: 10.1136/jnnp-2022-330412. Epub 2023 May 23.
5
Discovery of novel glioma serum biomarkers by proximity extension assay.通过邻位延伸分析发现新型胶质瘤血清生物标志物。
Clin Proteomics. 2023 Mar 24;20(1):12. doi: 10.1186/s12014-023-09400-5.
6
Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD).视神经脊髓炎谱系障碍(NMOSD)和髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)的诊断。
Klin Monbl Augenheilkd. 2022 Nov;239(11):1315-1324. doi: 10.1055/a-1918-1824. Epub 2022 Nov 21.
7
Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.视神经脊髓炎谱系障碍和髓鞘少突胶质细胞糖蛋白相关疾病中的血清和脑脊液生物标志物
Front Neurol. 2022 Mar 23;13:866824. doi: 10.3389/fneur.2022.866824. eCollection 2022.
8
Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders.血液中的胶质纤维酸性蛋白作为视神经脊髓炎谱系障碍的疾病生物标志物
Front Neurol. 2022 Mar 17;13:865730. doi: 10.3389/fneur.2022.865730. eCollection 2022.
9
Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease - A systematic review.血清神经胶质纤维酸性蛋白是一种体液生物标志物:对神经疾病有重要的预后价值——系统综述。
Int Immunopharmacol. 2022 Jun;107:108624. doi: 10.1016/j.intimp.2022.108624. Epub 2022 Mar 4.
10
Blood GFAP as an emerging biomarker in brain and spinal cord disorders.血液 GFAP 作为脑和脊髓疾病的新兴生物标志物。
Nat Rev Neurol. 2022 Mar;18(3):158-172. doi: 10.1038/s41582-021-00616-3. Epub 2022 Feb 3.